Progressive Lung Involvement during Steroid Therapy in Idiopathic Hypereosinophilic Syndrome

Ji-Young PARK; Ju-Young CHOI; Jung-Ji MIN; Yun-Su SIM; Gun-Woo PYUN; Youn-Ju NA; Min-Jung KANG; In-Sook KANG; Si-Nae LEE; Yookyung KIM; Jee-Hyong JEONG; Jin-Hwa LEE; Eun-Mee CHEON; Jung-Hyun CHANG.
Tuberculosis and Respiratory Diseases ; : 97-103, 2005.
Artículo en Ko | WPRIM | ID: wpr-155446

Documentos relacionados

  1. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
  2. Clinical and histopathological features of hypereosinophilic syndrome with cutaneous involvement: The Mayo Clinic Experience.
  3. Cardiac involvement in hypereosinophilia.
  4. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
  5. JAK inhibition for CD3<sup>-</sup> CD4<sup>+</sup> lymphocytic-variant hypereosinophilic syndrome.
  6. Detection of FIP1L1-PDGFRA fusion gene-positive cells in the skin lesion of a patient with hypereosinophilic syndrome.
  7. An algorithm-based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example.
  8. What we have learned about lymphocytic variant hypereosinophilic syndrome: A systematic literature review.
  9. Medical algorithm: Diagnosis and treatment of hypereosinophilic syndrome.
  10. Hypereosinophilic syndrome in Europe: Retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization.